YOLFTbeta
Polaris Group

Polaris Group

6550 · TW · Healthcare / Biotechnology

13.75TWD+0.25 (+1.85%)

Price History

Full chart

Market Stats

Previous Close13.50
Open13.40
Day Range13.40 – 13.80
52-Week Range16.75 – 73.92
Volume504.89K
Market Cap7.79B
P/E (TTM)0.00
Forward P/E0.00
EPS-8.66
Dividend Yield0.00%
Beta0.60
50-Day Avg20.45
200-Day Avg36.24

About

Polaris Group, together with its subsidiaries, offers biotechnology, pharmaceutical testing, and contract development and manufacturing services. The company engages in the research, development, manufacture and sale of new drugs. It also offers healthcare consulting, staffing, and MDS solutions. The company was incorporated in 2006 and is based in Grand Cayman, Cayman Islands.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Xianzhe Chen
  • Employees0
  • HeadquartersPO Box 309, Grand Cayman, Cayman Islands, KY1-1104, Taiwan
  • Websitehttps://www.polaris-group.com

Leadership

  • Mr. Xianzhe ChenChairman & CEO · b. 1950
  • Mr. Jack FitzgibbonsPresident & COO
  • Mr. Ray Wu M.B.A.Chief Financial Officer
  • Chien-Hsing ChangChief Strategy Officer
  • Kevin WuChief Information Security Officer
  • Yuexun WuDeputy General Manager

Financials

Income Statement

Currency: TWD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue----9.41M15.04M6.44M7.48M107.00M40.60M
Growth (%)-----+59.84%-57.19%+16.18%+1330.29%-62.05%
Cost of Revenue128.14M113.79M110.51M138.35M140.19M165.66M148.30M145.38M183.92M310.93M
Gross Profit-128.14M-113.79M-110.51M-138.35M-130.78M-150.62M-141.86M-137.90M-76.92M-270.32M
Gross Margin-----1389.83%-1001.40%-2203.15%-1843.35%-71.89%-665.79%
Operating Expense820.03M729.95M903.20M656.87M547.22M581.30M1.02B1.71B2.56B2.61B
Operating Income-948.17M-843.74M-1.01B-795.22M-678.00M-731.92M-1.16B-1.85B-2.63B-2.88B
Operating Margin-----7205.08%-4866.15%-17977.12%-24689.84%-2462.40%-7089.79%
EBITDA-801.89M-738.57M-886.71M-655.10M-521.75M-570.97M-990.13M-1.41B-2.17B-2.50B
EBITDA Margin-----5544.60%-3796.07%-15377.12%-18828.20%-2031.18%-6160.47%
Net Income-982.46M-898.45M-1.03B-829.76M-660.22M-740.49M-1.15B-1.58B-2.50B-3.95B
Net Income Margin-----7016.20%-4923.12%-17866.64%-21075.98%-2338.92%-9716.50%
R&D697.84M615.87M785.90M633.09M545.22M554.29M923.97M1.54B2.19B2.16B
R&D as % of Total Revenue----5794.07%3685.19%14349.60%20541.38%2049.04%5317.16%
Interest Expense50.27M55.61M44.85M35.49M5.16M14.67M11.05M32.59M57.06M99.36M
Interest Expense % of Total Revenue----54.78%97.56%171.63%435.64%53.33%244.72%

Balance Sheet

Currency: TWD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.97B2.22B1.98B4.11B3.36B7.82B9.22B9.10B9.09B8.17B
Total Liabilities1.73B1.22B1.34B496.61M480.85M608.23M545.18M1.46B2.32B2.87B
Total Equity207.30M1.00B640.55M3.61B2.88B7.21B8.67B7.37B6.70B5.30B
Cash357.77M706.82M394.88M2.61B152.21M5.88B7.23B3.62B1.95B1.83B
Total Debt1.52B1.01B1.03B276.08M325.59M436.75M382.62M1.20B1.88B2.35B
Net Debt1.16B306.51M639.37M-2.33B173.37M-5.44B-6.85B-2.42B-64.49M516.89M

Cash Flow

Currency: TWD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-782.53M-708.12M-778.68M-747.81M-585.70M-539.26M-1.03B-1.26B-2.03B-2.39B
Investing Cash Flow-268.54M-19.19M-58.66M-42.54M-1.79B1.02B199.68M-3.24B-1.63B-659.66M
Financing Cash Flow450.13M1.19B642.86M3.08B1.18M5.35B1.48B919.16M1.85B2.96B
Capital Expenditure305.08M20.71M43.23M50.17M51.68M204.34M69.63M333.18M1.66B795.28M
Free Cash Flow-1.09B-728.83M-821.91M-797.98M-637.38M-743.60M-1.10B-1.59B-3.69B-3.19B
FCF to OCF138.99%102.92%105.55%106.71%108.82%137.89%106.77%126.54%182.18%133.22%

Earnings

Report DateAug 21, 2022Nov 13, 2022Mar 16, 2023May 11, 2023
EPS Estimate-0.50-0.46--
EPS Actual-0.77-0.79-0.39-0.37
Surprise-54.00%-71.74%--
TimingAfter-hoursAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap7.79B
Enterprise Value8.94B
Trailing P/E0.00
Forward P/E0.00
Price / Sales114.59
Price / Book1.95
EPS-8.66
Book Value9.77
Revenue (TTM)67.95M
Gross Profit (TTM)-266.27M
EBITDA-2.26B
Profit Margin0.00%
Operating Margin-7429.21%
Return on Equity-81.10%
Return on Assets-20.42%
Shares Outstanding464.85M
Shares Float153.46M
Beta0.60
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Sep 17, 2026519.5017:1000